x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- apolipoproteinsRemove apolipoproteins filter
- Journal of Lipid ResearchRemove Journal of Lipid Research filter
Publication Date
Please choose a date range between 2015 and 2019.
Author
- Freedman, Barry I2
- Gebre, Abraham K2
- Absher, Devin M1
- Adimora, Adaora A1
- Adorni, Maria Pia1
- Angelin, Bo1
- Anuurad, Erdembileg1
- Aouizerat, Brad1
- Apro, Johanna1
- Arnett, Donna K1
- Aslibekyan, Stella1
- Azar-Kolakez, Ahlam1
- Barocco, Federica1
- Barochia, Amisha V1
- Belabbas, Khaldia1
- Berglund, Lars1
- Bernini, Franco1
- Boccara, Franck1
- Bowden, Donald W1
- Bozon, Dominique1
- Broijersén, Anders1
- Browne, Richard W1
- Butler, Kenneth1
- Caffarra, Paolo1
- Carel, Jean-Claude1
Keyword
- clinical studies4
- high density lipoprotein4
- atherosclerosis3
- cholesterol3
- apolipoprotein E2
- lipoproteins2
- low density lipoprotein2
- triglycerides2
- 27-hydroxycholesterol1
- apolipoprotein (a) sizes1
- apolipoprotein A-I1
- apolipoprotein E41
- apolipoprotein L11
- apolipoprotein M1
- asthma1
- ATP-binding cassette A11
- ATP-binding cassette G11
- biomarkers1
- cancer1
- cardiovascular diseases1
- clinically isolated syndrome1
- diet and dietary lipids1
- dietary fat1
- DNA methylation1
JLR Patient-Oriented and Epidemiological Research
11 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus
Journal of Lipid ResearchVol. 60Issue 8p1425–1431Published online: May 27, 2019- Mingxia Liu
- Cecilia Frej
- Carl D. Langefeld
- Jasmin Divers
- Donald W. Bowden
- J. Jeffrey Carr
- and others
Cited in Scopus: 16apoM is a minor HDL apolipoprotein and carrier for sphingosine-1-phosphate (S1P). HDL apoM and S1P concentrations are inversely associated with atherosclerosis progression in rodents. We evaluated associations between plasma concentrations of S1P, plasma concentrations of apoM, and HDL apoM levels with prevalent subclinical atherosclerosis and mortality in the African American-Diabetes Heart Study participants (N = 545). Associations between plasma S1P, plasma apoM, and HDL apoM with subclinical atherosclerosis and mortality were assessed using multivariate parametric, nonparametric, and Cox proportional hazards models. - Patient-Oriented and Epidemiological ResearchOpen Access
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease
Journal of Lipid ResearchVol. 60Issue 8p1449–1456Published online: June 5, 2019- Cinzia Marchi
- Maria Pia Adorni
- Paolo Caffarra
- Nicoletta Ronda
- Marco Spallazzi
- Federica Barocco
- and others
Cited in Scopus: 32HDL-like particles in human cerebrospinal fluid (CSF) promote the efflux of cholesterol from astrocytes toward the neurons that rely on this supply for their functions. We evaluated whether cell cholesterol efflux capacity of CSF (CSF-CEC) is impaired in Alzheimer's disease (AD) by analyzing AD (n = 37) patients, non-AD dementia (non-AD DEM; n = 16) patients, and control subjects (n = 39). As expected, AD patients showed reduced CSF Aβ 1-42, increased total and phosphorylated tau, and a higher frequency of the apoε4 genotype. - Patient-Oriented and Epidemiological ResearchOpen Access
Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women's Interagency HIV Study
Journal of Lipid ResearchVol. 59Issue 10p1967–1976Published online: July 16, 2018- Byambaa Enkhmaa
- Erdembileg Anuurad
- Wei Zhang
- Chin-Shang Li
- Robert Kaplan
- Jason Lazar
- and others
Cited in Scopus: 5We previously demonstrated an association between lipoprotein (a) [Lp(a)] levels and atherosclerosis in human immunodeficiency virus (HIV)-seropositive women. The effects of antiretroviral therapy (ART) on Lp(a) levels in relation to apo(a) size polymorphism remain unclear. ART effects on allele-specific apo(a) level (ASL), an Lp(a) level associated with individual apo(a) alleles within each allele-pair, were determined in 126 HIV-seropositive women. ART effects were tested by a mixed-effects model across pre-ART and post-ART first and third visits. - Patient-Oriented and Epidemiological ResearchOpen Access
High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics
Journal of Lipid ResearchVol. 58Issue 8p1713–1721Published online: June 27, 2017- Amisha V. Barochia
- Elizabeth M. Gordon
- Maryann Kaler
- Rosemarie A. Cuento
- Patricia Theard
- Debbie M. Figueroa
- and others
Cited in Scopus: 19Blood eosinophil counts and serum periostin levels are biomarkers of type 2 inflammation. Although serum levels of HDL and apoA-I have been associated with less severe airflow obstruction in asthma, it is not known whether serum lipids or lipoprotein particles are correlated with type 2 inflammation in asthmatics. Here, we assessed whether serum lipids and lipoproteins correlated with blood eosinophil counts or serum periostin levels in 165 atopic asthmatics and 163 nonasthmatic subjects with and without atopy. - Patient-Oriented and Epidemiological ResearchOpen Access
Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia
Journal of Lipid ResearchVol. 58Issue 6p1186–1195Published online: April 10, 2017- Hiten D. Mistry
- Lesia O. Kurlak
- Yosef T. Mansour
- Line Zurkinden
- Markus G. Mohaupt
- Geneviève Escher
Cited in Scopus: 25Preeclampsia is a pregnancy-specific condition that leads to increased cardiovascular risk in later life. A decrease in cholesterol efflux capacity is linked to CVD. We hypothesized that in preeclampsia there would be a disruption of maternal/fetal plasma to efflux cholesterol, as well as differences in the concentrations of both placental sterol 27-hydroxylase (CYP27A1) and apoA1 binding protein (AIBP). Total, HDL-, and ABCA1-mediated cholesterol effluxes were performed with maternal and fetal plasma from women with preeclampsia and normotensive controls (both n = 17). - Patient-Oriented and Epidemiological ResearchOpen Access
Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors
Journal of Lipid ResearchVol. 58Issue 5p982–993Published online: March 8, 2017- Sophia Morel
- Jade Leahy
- Maryse Fournier
- Benoit Lamarche
- Carole Garofalo
- Guy Grimard
- and others
Cited in Scopus: 39Survivors of acute lymphoblastic leukemia (ALL), the most common cancer in children, are at increased risk of developing late cardiometabolic conditions. However, the mechanisms are not fully understood. This study aimed to characterize the plasma lipid profile, Apo distribution, and lipoprotein composition of 80 childhood ALL survivors compared with 22 healthy controls. Our results show that, despite their young age, 50% of the ALL survivors displayed dyslipidemia, characterized by increased plasma triglyceride (TG) and LDL-cholesterol, as well as decreased HDL-cholesterol. - Patient-Oriented and Epidemiological ResearchOpen Access
Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge
Journal of Lipid ResearchVol. 57Issue 12p2200–2207Published online: October 24, 2016- Chao-Qiang Lai
- Mary K. Wojczynski
- Laurence D. Parnell
- Bertha A. Hidalgo
- Marguerite Ryan Irvin
- Stella Aslibekyan
- and others
Cited in Scopus: 27Postprandial lipemia (PPL), the increased plasma TG concentration after consuming a high-fat meal, is an independent risk factor for CVD. Individual responses to a meal high in fat vary greatly, depending on genetic and lifestyle factors. However, only a few loci have been associated with TG-PPL response. Heritable epigenomic changes may be significant contributors to the unexplained inter-individual PPL variability. We conducted an epigenome-wide association study on 979 subjects with DNA methylation measured from CD4+ T cells, who were challenged with a high-fat meal as a part of the Genetics of Lipid Lowering Drugs and Diet Network study. - Patient-Oriented and Epidemiological ResearchOpen Access
Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France
Journal of Lipid ResearchVol. 57Issue 3p482–491Published online: January 22, 2016- René Wintjens
- Dominique Bozon
- Khaldia Belabbas
- Félicien MBou
- Jean-Philippe Girardet
- Patrick Tounian
- and others
Cited in Scopus: 20Autosomal dominant hypercholesterolemia (ADH) is a human disorder characterized phenotypically by isolated high-cholesterol levels. Mutations in the low density lipoprotein receptor (LDLR), APOB, and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes are well known to be associated with the disease. To characterize the genetic background associated with ADH in France, the three ADH-associated genes were sequenced in a cohort of 120 children and 109 adult patients. Fifty-one percent of the cohort had a possible deleterious variant in LDLR, 3.1% in APOB, and 1.7% in PCSK9. - Patient-Oriented and Epidemiological ResearchOpen Access
Characterization of circulating APOL1 protein complexes in African Americans
Journal of Lipid ResearchVol. 57Issue 1p120–130Published online: November 18, 2015- Allison Weckerle
- James A. Snipes
- Dongmei Cheng
- Abraham K. Gebre
- Julie A. Reisz
- Mariana Murea
- and others
Cited in Scopus: 36APOL1 gene renal-risk variants are associated with nephropathy and CVD in African Americans; however, little is known about the circulating APOL1 variant proteins which reportedly bind to HDL. We examined whether APOL1 G1 and G2 renal-risk variant serum concentrations or lipoprotein distributions differed from nonrisk G0 APOL1 in African Americans without nephropathy. Serum APOL1 protein concentrations were similar regardless of APOL1 genotype. In addition, serum APOL1 protein was bound to protein complexes in two nonoverlapping peaks, herein referred to as APOL1 complex A (12.2 nm diameter) and complex B (20.0 nm diameter). - Patient-Oriented and Epidemiological ResearchOpen Access
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients
Journal of Lipid ResearchVol. 56Issue 10p2010–2018Published online: August 4, 2015- Kelly Fellows
- Tomas Uher
- Richard W. Browne
- Bianca Weinstock-Guttman
- Dana Horakova
- Helena Posova
- and others
Cited in Scopus: 35The purpose of this work was to investigate the associations of serum cholesterol and apolipoproteins with measures of blood-brain barrier (BBB) permeability and CNS inflammation following the first clinical demyelinating event. This study included 154 patients [67% female; age, 29.5 ± 8.2 years (mean ± SD)] enrolled in a multi-center study of interferon β1-a treatment following the first demyelinating event. Blood and cerebrospinal fluid (CSF) were obtained at screening prior to treatment. A comprehensive serum lipid profile and multiple surrogate markers of BBB breakdown and CNS immune activity were obtained. - Patient-Oriented and Epidemiological ResearchOpen Access
Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients
Journal of Lipid ResearchVol. 56Issue 8p1633–1639Published online: June 19, 2015- Johanna Apro
- Paolo Parini
- Anders Broijersén
- Bo Angelin
- Mats Rudling
Cited in Scopus: 6At a given level of serum cholesterol, patients with T2D have an increased risk of developing atherosclerosis compared with nondiabetic subjects. We hypothesized that T2D patients have an increased interstitial fluid (IF)-to-serum gradient ratio for LDL, due to leakage over the vascular wall. Therefore, lipoprotein profiles in serum and IF from 35 T2D patients and 35 healthy controls were assayed using fast performance liquid chromatography. The IF-to-serum gradients for VLDL and LDL cholesterol, as well as for apoB, were clearly reduced in T2D patients compared with healthy controls.